{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:26:10Z","timestamp":1788279970662,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["P50 AA 26117"],"award-info":[{"award-number":["P50 AA 26117"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["F31 AA 29588"],"award-info":[{"award-number":["F31 AA 29588"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["T32 AA 07565"],"award-info":[{"award-number":["T32 AA 07565"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejphar.2026.179199","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:16:29Z","timestamp":1786029389000},"page":"179199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effects of chronic treatment with acetylcholine receptor agonists on ethanol self-administration in male cynomolgus monkeys"],"prefix":"10.1016","volume":"1032","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2026-0232","authenticated-orcid":false,"given":"Emily A.","family":"Cronin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8672-8323","authenticated-orcid":false,"given":"Lindsey K.","family":"Galbo-Thomma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip M.","family":"Epperly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Blough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2946-1057","authenticated-orcid":false,"given":"Antonio","family":"Landavazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1778-4625","authenticated-orcid":false,"given":"Paul W.","family":"Czoty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179199_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/bs.irn.2024.02.002","article-title":"Repurposing drugs for treatment of alcohol use disorder","volume":"175","author":"Aubin","year":"2024","journal-title":"Int. Rev. Neurobiol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179199_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41386-018-0137-2","article-title":"Sex differences in stress reactivity in arousal and attention systems","volume":"44","author":"Bangasser","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.179199_bib2","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1021\/acschemneuro.8b00481","article-title":"The muscarinic acetylcholine receptor M5: therapeutic implications and allosteric modulation","volume":"10","author":"Bender","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179199_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/acschemneuro.7b00001","article-title":"Classics in chemical neuroscience: Xanomeline","volume":"8","author":"Bender","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179199_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1345\/aph.1L160","article-title":"Trospium chloride treatment of overactive bladder","volume":"43","author":"Biastre","year":"2009","journal-title":"Ann. Pharmacother."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179199_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archneur.1997.00550160091022","article-title":"Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease","volume":"54","author":"Bodick","year":"1997","journal-title":"Arch. Neurol."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179199_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2020.02.446","article-title":"Efficacy and safety of xanomeline, a M1\/M4 receptor preferencing agonist, plus trospium, a peripheral muscarinic antagonist, in schizophrenia: phase 2 clinical trial results","volume":"87","author":"Brannan","year":"2020","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179199_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/187152710790966597","article-title":"Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders","volume":"9","author":"Chatterjee","year":"2010","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179199_bib9","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1530-0277.2011.01675.x","article-title":"Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements","volume":"36","author":"Childs","year":"2012","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179199_bib10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/syn.20795","article-title":"Decreased Beta2*-nicotinic acetylcholine receptor availability after chronic ethanol exposure in nonhuman primates","volume":"64","author":"Cosgrove","year":"2010","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179199_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/npp.2010.185","article-title":"Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys","volume":"36","author":"Czoty","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179199_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1124\/jpet.113.204321","article-title":"Effects of chronic methylphenidate on cocaine self-administration under a progressive-ratio schedule of reinforcement in rhesus monkeys","volume":"345","author":"Czoty","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"10.1016\/j.ejphar.2026.179199_bib13","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/acer.12854","article-title":"Varenicline for treatment of alcohol dependence: a randomized, placebo\u2010controlled trial","volume":"39","author":"de Bejczy","year":"2015","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2026.179199_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2014.10.050","article-title":"Enhanced self-administration of alcohol in muscarinic acetylcholine M4 receptor knockout mice","volume":"746","author":"De La Cour","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179199_bib15","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s41386-019-0390-z","article-title":"Effects of stimulation of mu opioid and nociceptin\/orphanin FQ peptide (NOP) receptors on alcohol drinking in rhesus monkeys","volume":"44","author":"Flynn","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179199_bib16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1530-0277.1988.tb00255.x","article-title":"Loss of cholinergic muscarinic receptors in the frontal cortex of alcohol abusers","volume":"12","author":"Freund","year":"1988","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179199_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0741-8329(89)90069-4","article-title":"Loss of muscarinic and benzodiazepine neuroreceptors from hippocampus of alcohol abusers","volume":"6","author":"Freund","year":"1989","journal-title":"Alcohol"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179199_bib18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00213-010-2160-9","article-title":"A preliminary investigation of varenicline for heavy drinking smokers","volume":"215","author":"Fucito","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2026.179199_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.alcohol.2021.10.001","article-title":"Social dominance in monkeys: lack of effect on ethanol self-administration during schedule induction","volume":"98","author":"Galbo","year":"2022","journal-title":"Alcohol"},{"issue":"10","key":"10.1016\/j.ejphar.2026.179199_bib20","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/acer.15163","article-title":"Influence of social rank on the development of long-term ethanol drinking trajectories in nonhuman primates","volume":"47","author":"Galbo-Thomma","year":"2023","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179199_bib21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1124\/jpet.123.001854","article-title":"Cognitive-enhancing effects of acetylcholine receptor agonists in group-housed cynomolgus monkeys who drink ethanol","volume":"389","author":"Galbo-Thomma","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179199_bib22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s43440-025-00695-9","article-title":"[11C]MK-6884 PET imaging reveals lower M4 muscarinic acetylcholine receptor availability following cocaine self-administration in male rats","volume":"77","author":"Gollapelli","year":"2025","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179199_bib23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1124\/jpet.111.185538","article-title":"Effects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys","volume":"339","author":"Gould","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179199_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1124\/jpet.105.090134","article-title":"Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor","volume":"315","author":"Grant","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2026.179199_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bbr.2016.06.022","article-title":"A threshold model for opposing actions of acetylcholine on reward behavior: molecular mechanisms and implications for treatment of substance abuse disorders","volume":"312","author":"Grasing","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179199_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0006-8993(93)90268-R","article-title":"Muscarinic and nicotinic receptor changes in the cortex and thalamus of brains of chronic alcoholics","volume":"620","author":"Hellstr\u00f6m-Lindahl","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2026.179199_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.drugalcdep.2014.01.027","article-title":"Changes in the \u03b14\u03b22* nicotinic acetylcholine system during chronic controlled alcohol exposure in nonhuman primates","volume":"138","author":"Hillmer","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179199_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/ADM.0b013e31829623f4","article-title":"A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence","volume":"7","author":"Litten","year":"2013","journal-title":"J. Addict. Med."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179199_bib30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopsych.2009.01.029","article-title":"Varenicline reduces alcohol self-administration in heavy-drinking smokers","volume":"66","author":"McKee","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179199_bib29","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/ntr\/ntv207","article-title":"Sex differences in varenicline efficacy for smoking cessation a meta-analysis","volume":"18","author":"McKee","year":"2015","journal-title":"Nicotine Tob. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179199_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00213-012-2717-x","article-title":"Varenicline decreases alcohol consumption in heavy-drinking smokers","volume":"223","author":"Mitchell","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2026.179199_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.745783","article-title":"Sex differences in the nicotinic acetylcholine receptor system of rodents: impacts on nicotine and alcohol reward behaviors","volume":"15","author":"Moen","year":"2021","journal-title":"Front. Neurosci."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179199_bib33","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1080\/14656566.2021.1892641","article-title":"New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies","volume":"22","author":"Morley","year":"2021","journal-title":"Expert Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179199_bib34","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.drugalcdep.2013.06.019","article-title":"Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence","volume":"133","author":"Plebani","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179199_bib35","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuropharm.2006.10.016","article-title":"Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid","volume":"52","author":"Rollema","year":"2007","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.ejphar.2026.179199_bib37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1176\/appi.ajp.2008.06091591","article-title":"Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia","volume":"165","author":"Shekhar","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179199_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.9758\/cpn.24.1253","article-title":"Xanomeline-trospium (CobenfyTM) for schizophrenia: a review of the literature","volume":"23","author":"Smith","year":"2025","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"11","key":"10.1016\/j.ejphar.2026.179199_bib39","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s40263-022-00964-8","article-title":"Clinical effectiveness of muscarinic receptor-targeted interventions in neuropsychiatric disorders: a systematic review","volume":"36","author":"Vaidya","year":"2022","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1016\/j.ejphar.2026.179199_bib40","first-page":"1087","article-title":"Induction and maintenance of ethanol self-administration in cynomolgus monkeys (Macaca fascicularis): long-term characterization of sex and individual differences","volume":"25","author":"Vivian","year":"2001","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179199_bib41","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopsych.2020.02.019","article-title":"Acetylcholine muscarinic M4 receptors as a therapeutic target for alcohol use disorder: converging evidence from humans and rodents","volume":"88","author":"Walker","year":"2020","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179199_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.907","article-title":"M1 muscarinic receptor activation decreases alcohol consumption via a reduction in consummatory behavior","volume":"10","author":"Walker","year":"2022","journal-title":"Pharmacol. Res. Perspect."},{"issue":"22","key":"10.1016\/j.ejphar.2026.179199_bib43","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1111\/bph.16081","article-title":"Targeting muscarinic receptors for the treatment of alcohol use disorders: opportunities and hurdles for clinical development","volume":"181","author":"Walker","year":"2024","journal-title":"Br. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:01:19Z","timestamp":1788278479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926006813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"alternative-id":["S0014299926006813"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179199","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of chronic treatment with acetylcholine receptor agonists on ethanol self-administration in male cynomolgus monkeys","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"179199"}}